|
Volumn 46, Issue 7, 2001, Pages 1533-1539
|
Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms
a,b a,b c c c c |
Author keywords
Cost; Formulary changes; Gastroesophageal reflux disease; Health care utilization; Proton pump inhibitor
|
Indexed keywords
LANSOPRAZOLE;
OMEPRAZOLE;
PROTON PUMP INHIBITOR;
ADULT;
AGED;
ARTICLE;
DISEASE SEVERITY;
DRUG FORMULARY;
FEMALE;
GASTROESOPHAGEAL REFLUX;
HEALTH CARE COST;
HEALTH CARE UTILIZATION;
HEARTBURN;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
SYMPTOMATOLOGY;
TREATMENT FAILURE;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
FEMALE;
FORMULARIES;
GASTROESOPHAGEAL REFLUX;
HEALTH CARE COSTS;
HEARTBURN;
HOSPITALS, VETERANS;
HUMANS;
MALE;
MEDICAL RECORDS;
MIDDLE AGED;
OMEPRAZOLE;
OUTCOME ASSESSMENT (HEALTH CARE);
PATIENT SATISFACTION;
PROTON PUMPS;
UNITED STATES;
|
EID: 0034939824
PISSN: 01632116
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1010608408684 Document Type: Article |
Times cited : (12)
|
References (11)
|